Andrew W. Roberts - Publications, H-index & Citations

Andrew W. Roberts

walter and eliza hall institute of medical research

87H指数

465论文数

3.4W被引数

收录论文 98

发表时间

The stress-sensing MARCH5 axis governs blood cancer apoptotic resilience via tractable protein–protein interactions 压力感应的MARCH5轴通过可调节的蛋白质-蛋白质相互作用调控血液癌症的凋亡抗性

Blood

IF23.1

2026-09-11

PREAI

Thomas E. Lew; Mark F. van Delft; Luuk Heitink; Simon A. Cobbold; Christine A. White; Jason A. R. Bong; Philip H. Hittmeyer; Amelia H. Zhu; Vineet Vaibhav; Jumana Yousef; Laura Dagley; Christopher D. Riffkin; Angela Georgiou; Adrienne Hilton; Allan S. Huang; Yin Yuan; Miles B. Horton; Mark A. Dawson; Andrew W. Roberts; David C. S. Huang

Myeloid/lymphoid neoplasms with eosinophilia and ZMYM2::FLT3 fusion: clinical, pathological and molecular clues to a cryptic diagnosis 髓系/淋巴系伴嗜酸性粒细胞增多和ZMYM2::FLT3融合的新生物：临床、病理及分子线索揭示隐匿诊断

Pathology

IF3

2026-05-07

PREAI

Imogen Caldwell; Samuel Grigg; Leanne Berkahn; Isaac Goncalves; Andrew W. Roberts; Piers Blombery; Ing-Soo Tiong

Blood: flowing stronger than ever after 80 years 血液：80年后依然流淌，比以往任何时候都更强。

Blood

IF23.1

2026-01-01

OAAI

Andrew W. Roberts

Antifungal prophylaxis in patients with FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD)-positive acute myeloid leukaemia receiving sorafenib during initial induction and consolidation treatment in ALLG AMLM16 trial FLT3-ITD阳性急性髓系白血病患者在接受索拉非尼初始诱导和巩固治疗期间的抗真菌预防（ALLG AMLM16试验）

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IF3.6

2025-10-01

PREAI

Neoh, Chin Fen; Yong, Michelle K.; Rowley, Leesa; Roberts, Andrew W.; Kennedy, Glen A.; He, Simon; Schwarer, Anthony P.; Bilmon, Ian A.; Wei, Andrew H.; Slavin, Monica A.

Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice 慢性淋巴细胞白血病对靶向疗法的耐药性：临床和诊断实践中的现状与展望

Leukemia

IF13.4

2025-06-24

OAAI

Piers Blombery; Thomas Chatzikonstantinou; Marina Gerousi; Richard Rosenquist; Gianluca Gaidano; Sarka Pospisilova; Andrew W. Roberts; Richard W. Birkinshaw; Davide Rossi; Lydia Scarfo; John F. Seymour; Stephan Stilgenbauer; Adrian Wiestner; Jennifer A. Woyach; Jennifer R. Brown; Paolo Ghia; Kostas Stamatopoulos

Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer 乳腺癌经维奈克拉为基础的疗法后出现的BAX突变克隆性造血

Blood Advances

IF7.1

2025-05-30

OAAI

Ing S. Tiong; Tamia Nguyen; Chong C. Chua; Charis E. Teh; Christine Muttiah; Sarah Ftouni; John F. Seymour; Daniel Gray; Andrew W. Roberts; Sarah-Jane Dawson; Geoffrey J. Lindeman; Piers Blombery

Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins 对渗透的血癌细胞进行再评估试验，测试维奈克拉或选择性靶向促生存BCL2蛋白的其他BH3模拟剂

CELL DEATH AND DIFFERENTIATION

IF15.4

2025-04-09

OAAI

Gong, Jia-Nan; Djajawi, Tirta M.; Moujalled, Donia M.; Pomilio, Giovanna; Khong, Tiffany; Zhang, Li-Ping; Fedele, Pasquale L.; Low, Michael S.; Anderson, Mary Ann; Riffkin, Christopher D.; White, Christine A.; Lan, Ping; Lessene, Guillaume; Herold, Marco J.; Strasser, Andreas; Spencer, Andrew; Grigoriadis, George; Wei, Andrew H.; van Delft, Mark F.; Roberts, Andrew W.; Huang, David C. S.

Enterocolitis associated with glofitamab-First report and clinicopathological findings in three cases 与Glofitamab相关的肠结肠炎——首例报道及三例的临床病理特征

BRITISH JOURNAL OF HAEMATOLOGY

IF3.8

2025-03-19

OAAI

Sean McKeague; Molly Robertson; Sam van der Linde; Christine Khoo; Jonathan Segal; Sean Harrop; Adrian Minson; Andrew W. Roberts; Michael Dickinson

How comparable are patient outcomes in the real-world with populations studied in pivotal AML trials?

BLOOD CANCER JOURNAL

IF11.6

2024-03-26

OAAI

Tiong, Ing Soo; Wall, Meaghan; Bajel, Ashish; Kalro, Akash; Fleming, Shaun; Roberts, Andrew W.; Thiagarajah, Nisha; Chua, Chong Chyn; Latimer, Maya; Yeung, David; Marlton, Paula; Johnston, Amanda; Enjeti, Anoop; Fong, Chun Yew; Cull, Gavin; Larsen, Stephen; Kennedy, Glen; Schwarer, Anthony; Kipp, David; Ramanathan, Sundra; Verner, Emma; Tiley, Campbell; Morris, Edward; Hahn, Uwe; Moore, John; Taper, John; Purtill, Duncan; Warburton, Pauline; Stevenson, William; Murphy, Nicholas; Tan, Peter; Beligaswatte, Ashanka; Mutsando, Howard; Hertzberg, Mark; Shortt, Jake; Szabo, Ferenc; Dunne, Karin; Wei, Andrew H.

Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon

BLOOD ADVANCES

IF7.1

2024-03-15

OAAI

Lew, Thomas E.; Bennett, Rory; Lin, Victor S.; Whitechurch, Ashley; Handunnetti, Sasanka M.; Marlton, Paula; Shen, Yandong; Mulligan, Stephen P.; Casan, Joshua; Blombery, Piers; Tam, Constantine S.; Roberts, Andrew W.; Seymour, John F.; Thompson, Philip A.; Anderson, Mary A.

Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies

HEMASPHERE

IF14.6

2023-12-01

OAAI

Gopalakrishnan, Sathej; Menon, Rajeev; Suleiman, Ahmed A.; Kater, Arnon P.; Stilgenbauer, Stephan; Seymour, John F.; Chyla, Brenda; Lu, Tong; Kim, Su Young; Roberts, Andrew W.; Woyach, Jennifer A.; Mensing, Sven; Salem, Ahmed Hamed

Venetoclax treatment in patients with cancer has limited impact on circulating T and NK cells 维尼托克治疗癌症患者对循环T和NK细胞的影响有限

BLOOD ADVANCES

IF7.1

2023-06-15

OAAI

Teh, Charis E.; Peng, Hongke; Luo, Meng-Xiao; Tan, Tania; Trussart, Marie; Howson, Lauren J.; Chua, Chong Chyn; Muttiah, Christine; Brown, Fiona; Ritchie, Matthew E.; Wei, Andrew H.; Roberts, Andrew W.; Bryant, Vanessa L.; Anderson, Mary Ann; Lindeman, Geoffrey J.; Huang, David C. S.; Thijssen, Rachel; Gray, Daniel H. D.

BCL2 Inhibition: A New Paradigm for the Treatment of AML and Beyond

HEMASPHERE

IF14.6

2023-06-01

OAAI

Wei, Andrew H. H.; Roberts, Andrew W.

Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance

BLOOD ADVANCES

IF7.1

2022-10-13

OAAI

Blombery, Piers; Thompson, Ella R.; Lew, Thomas E.; Tiong, Ing Soo; Bennett, Rory; Cheah, Chan Y.; Lewis, Katharine Louise; Handunnetti, Sasanka M.; Tang, Chloe Pek Sang; Roberts, Andrew; Seymour, John F.; Tam, Constantine S.

Germline MBD4 deficiency causes a multi-tumor predisposition syndrome

AMERICAN JOURNAL OF HUMAN GENETICS

IF8.1

2022-05-01

OAAI

Palles, Claire; West, Hannah D.; Chew, Edward; Galavotti, Sara; Flensburg, Christoffer; Grolleman, Judith E.; Jansen, Erik A. M.; Curley, Helen; Chegwidden, Laura; Arbe-Barnes, Edward H.; Lander, Nicola; Truscott, Rebekah; Pagan, Judith; Bajel, Ashish; Sherwood, Kitty; Martin, Lynn; Thomas, Huw; Georgiou, Demetra; Fostira, Florentia; Goldberg, Yael; Adams, David J.; van der Biezen, Simone A. M.; Christie, Michael; Clendenning, Mark; Thomas, Laura E.; Deltas, Constantinos; Dimovski, Aleksandar J.; Dymerska, Dagmara; Lubinski, Jan; Mahmood, Khalid; van der Post, Rachel S.; Sanders, Mathijs; Weitz, Jurgen; Taylor, Jenny C.; Turnbull, Clare; Vreede, Lilian; van Wezel, Tom; Whalley, Celina; Arnedo-Pac, Claudia; Caravagna, Giulio; Cross, William; Chubb, Daniel; Frangou, Anna; Gruber, Andreas J.; Kinnersley, Ben; Noyvert, Boris; Church, David; Graham, Trevor; Houlston, Richard; Lopez-Bigas, Nuria; Sottoriva, Andrea; Wedge, David; Jenkins, Mark A.; Kuiper, Roland P.; Roberts, Andrew W.; Cheadle, Jeremy P.; Ligtenberg, Marjolijn J. L.; Hoogerbrugge, Nicoline; Koelzer, Viktor H.; Rivas, Andres Dacal; Winship, Ingrid M.; Ponte, Clara Ruiz; Buchanan, Daniel D.; Power, Derek G.; Green, Andrew; Tomlinson, Ian P. M.; Sampson, Julian R.; Majewski, Ian J.; de Voer, Richarda M.

Acute leukaemia in Australia: outcomes have improved, but there is still much to do

MEDICAL JOURNAL OF AUSTRALIA

IF8.5

2022-03-03

PREAI

Yeoh, Zhi Han; Roberts, Andrew W.

Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach COMMENT

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2022-02-25

OAAI

Arber, Daniel A.; Hasserjian, Robert P.; Orazi, Attilio; Mathews, Vikram; Roberts, Andrew W.; Schiffer, Charles A.; Roug, Anne Stidsholt; Cazzola, Mario; Doehner, Hartmut; Tefferi, Ayalew

Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies

BLOOD ADVANCES

IF7.1

2022-02-17

OAAI

Tam, Constantine S.; Dimopoulos, Meletios; Garcia-Sanz, Ramon; Trotman, Judith; Opat, Stephen; Roberts, Andrew W.; Owen, Roger; Song, Yuqin; Xu, Wei; Zhu, Jun; Li, Jianyong; Qiu, Lugui; D'Sa, Shirley; Jurczak, Wojciech; Cull, Gavin; Marlton, Paula; Gottlieb, David; Munoz, Javier; Phillips, Tycel; Du, Chenmu; Ji, Meng; Zhou, Lei; Guo, Haiyi; Zhu, Hongjie; Chan, Wai Y.; Cohen, Aileen; Novotny, William; Huang, Jane; Tedeschi, Alessandra

Single-cell sequencing demonstrates complex resistance landscape in CLL and MCL treated with BTK and BCL2 inhibitors

BLOOD ADVANCES

IF7.1

2022-01-18

OAAI

Thompson, Ella R.; Nguyen, Tamia; Kankanige, Yamuna; Markham, John F.; Anderson, Mary Ann; Handunnetti, Sasanka M.; Thijssen, Rachel; Yeh, Paul Sung-Hao; Tam, Constantine S.; Seymour, John F.; Roberts, Andrew W.; Westerman, David A.; Blombery, Piers

Comprehensive characterization of single-cell full-length isoforms in human and mouse with long-read sequencing

GENOME BIOLOGY

IF9.4

2021-11-11

OAAI

Tian, Luyi; Jabbari, Jafar S.; Thijssen, Rachel; Gouil, Quentin; Amarasinghe, Shanika L.; Voogd, Oliver; Kariyawasam, Hasaru; Du, Mei R. M.; Schuster, Jakob; Wang, Changqing; Su, Shian; Dong, Xueyi; Law, Charity W.; Lucattini, Alexis; Prawer, Yair David Joseph; Collar-Fernandez, Coralina; Chung, Jin D.; Naim, Timur; Chan, Audrey; Ly, Chi Hai; Lynch, Gordon S.; Ryall, James G.; Anttila, Casey J. A.; Peng, Hongke; Anderson, Mary Ann; Flensburg, Christoffer; Majewski, Ian; Roberts, Andrew W.; Huang, David C. S.; Clark, Michael B.; Ritchie, Matthew E.

研究方向